Literature DB >> 15831462

Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice.

Anna Lasorella1, Gerson Rothschild, Yoshifumi Yokota, Robert G Russell, Antonio Iavarone.   

Abstract

The inhibitor of differentiation Id2 is a target of the retinoblastoma (Rb) protein during mouse embryogenesis. In Rb(+/-) mice, LOH at the wild-type Rb allele initiates pituitary adenocarcinoma, a tumor derived from embryonic melanotropes. Here we identify a critical role for Id2 in initiation, growth, and angiogenesis of pituitary tumors from Rb(+/-) mice. We show that proliferation and differentiation are intimately coupled in Rb(+/-) pituitary cells before tumor initiation. In Id2-null pituitaries, premature activation of basic helix-loop-helix-mediated transcription and expression of the cdk inhibitor p27(Kip1) impairs the proliferation of melanotropes and tumor initiation. Without Id2, Rb(+/-) mice have fewer early tumor lesions and a markedly decreased proliferation rate of the tumor foci. Expression of Id2 by pituitary tumor cells promotes growth and angiogenesis by functioning as a master regulator of vascular endothelial growth factor (VEGF). In human neuroblastoma, the N-Myc-driven expression of Id2 is sufficient and necessary for expression of VEGF. These results establish that aberrant Id2 activity directs initiation and progression of embryonal cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831462      PMCID: PMC1084294          DOI: 10.1128/MCB.25.9.3563-3574.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2.

Authors:  Y Yokota; A Mansouri; S Mori; S Sugawara; S Adachi; S Nishikawa; P Gruss
Journal:  Nature       Date:  1999-02-25       Impact factor: 49.962

2.  Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.

Authors:  Mariko Fukuma; Hajime Okita; Jun-Ichi Hata; Akihiro Umezawa
Journal:  Oncogene       Date:  2003-01-09       Impact factor: 9.867

3.  Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages.

Authors:  Antonio Iavarone; Emerson R King; Xu-Ming Dai; Gustavo Leone; E Richard Stanley; Anna Lasorella
Journal:  Nature       Date:  2004-12-23       Impact factor: 49.962

4.  The Mad and Myc basic domains are functionally equivalent.

Authors:  Mikhail A Nikiforov; Nikita Popov; Iulia Kotenko; Marie Henriksson; Michael D Cole
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

Review 5.  Naturally death-resistant precursor cells revealed as the origin of retinoblastoma.

Authors:  Emmanuelle Trinh; Eros Lazzerini Denchi; Kristian Helin
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

6.  Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma.

Authors:  Danian Chen; Izhar Livne-bar; Jackie L Vanderluit; Ruth S Slack; Mahima Agochiya; Rod Bremner
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

7.  BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3.

Authors:  Qi Long Ying; Jennifer Nichols; Ian Chambers; Austin Smith
Journal:  Cell       Date:  2003-10-31       Impact factor: 41.582

8.  Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1alpha expression.

Authors:  Julia I Bárdos; Noan-Minh Chau; Margaret Ashcroft
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice.

Authors:  Koji Aoki; Yoshitaka Tamai; Shigeo Horiike; Masanobu Oshima; Makoto M Taketo
Journal:  Nat Genet       Date:  2003-11-16       Impact factor: 38.330

10.  Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors.

Authors:  Marianna B Ruzinova; Rebecca A Schoer; William Gerald; James E Egan; Pier Paolo Pandolfi; Shahin Rafii; Katia Manova; Vivek Mittal; Robert Benezra
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

View more
  56 in total

1.  Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.

Authors:  Solange Landreville; Duanduan Ma; Jun Wu; J William Harbour
Journal:  Curr Eye Res       Date:  2010-05       Impact factor: 2.424

2.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

Review 3.  Racing to block tumorigenesis after pRb loss: an innocuous point mutation wins with synthetic lethality.

Authors:  Frederick Bauzon; Liang Zhu
Journal:  Cell Cycle       Date:  2010-06-01       Impact factor: 4.534

4.  The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system.

Authors:  Anna Lasorella; Antonio Iavarone
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

5.  Adaptive response of vascular endothelial cells to an acute increase in shear stress frequency.

Authors:  Ji Zhang; Morton H Friedman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-12       Impact factor: 4.733

6.  Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.

Authors:  M J Gray; N A Dallas; G Van Buren; L Xia; A D Yang; R J Somcio; P Gaur; L S Mangala; P E Vivas-Mejia; F Fan; A M Sanguino; G E Gallick; G Lopez-Berestein; A K Sood; L M Ellis
Journal:  Oncogene       Date:  2008-09-22       Impact factor: 9.867

7.  Role of BRAFV600E in the first preclinical model of multifocal infiltrating myopericytoma development and microenvironment.

Authors:  Peter M Sadow; Carmen Priolo; Simona Nanni; Florian A Karreth; Mark Duquette; Roberta Martinelli; Amjad Husain; John Clohessy; Heinz Kutzner; Thomas Mentzel; Christopher V Carman; Antonella Farsetti; Elizabeth Petri Henske; Emanuele Palescandolo; Laura E Macconaill; Seum Chung; Guido Fadda; Celestino Pio Lombardi; Antonina M De Angelis; Oreste Durante; John A Parker; Alfredo Pontecorvi; Harold F Dvorak; Christopher Fletcher; Pier Paolo Pandolfi; Jack Lawler; Carmelo Nucera
Journal:  J Natl Cancer Inst       Date:  2014-07-25       Impact factor: 13.506

8.  Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice.

Authors:  Hongbo Wang; Frederick Bauzon; Peng Ji; Xiaoliang Xu; Daqian Sun; Joseph Locker; Rani S Sellers; Keiko Nakayama; Keiich I Nakayama; David Cobrinik; Liang Zhu
Journal:  Nat Genet       Date:  2009-12-06       Impact factor: 38.330

9.  Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).

Authors:  Fan Su; Bin Li; Jian Wang; Xiaolin Xu; Ruojin Ren; Liaoqing Li; Fei Gao; Xiaochao Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-29       Impact factor: 3.117

10.  FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells.

Authors:  Weidong Han; Zhiqiang Wu; Yali Zhao; Yuanguang Meng; Yiling Si; Jie Yang; Xiaobing Fu; Li Yu
Journal:  Nucleic Acids Res       Date:  2009-05-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.